Vancomycin does not benefit persistently febrile neutropenic people with cancer: Abstracted from: Cometta A, Kern WV, De Bock R, et al. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin–tazobactam monotherapy. Clin Infect Dis 2003;37:382–9.

• Book ID: 116394869
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 201 KB
• Volume: 30
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2003.11.008